The radiopharmaceuticals presented in our portfolio provide outstanding features and characteristics, such as excellent in vivo characteristics and particularly high in vivo stability. Speedness and simplicity of synthesis is an important requirement for our radiopharmaceuticals. These characteristics are based in part on dedicated and unique labeling techniques, which we consider to be key technologies for future developments.
Adapted to this, we are offering very compact, fully automated synthesis units for the GMP production of such radiopharmaceuticals, for which tailor-made synthesis cassettes and reagent sets are available.
